the serum half-life , urine levels , distribution volume , protein binding and potential antibacterial activity in the urine renders sulphadiazine the preferred component in a combination tablet together with trimethoprim for the treatment of urinary tract infections .
C0038675
sulphadiazine
C0042029
of urinary tract infections